Invenomic Capital Management’s HyreCar Inc. Common Stock HYRE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
– Sell
-502,881
Closed -$463K – 178
2022
Q3
$463K Sell
502,881
-460,655
-48% -$430K 0.04% 145
2022
Q2
$588K Buy
963,536
+5,257
+0.5% +$6.74K 0.04% 140
2022
Q1
$1.86M Buy
958,279
+750,534
+361% +$2.32M 0.2% 102
2021
Q4
$979K Buy
207,745
+131,881
+174% +$824K 0.21% 108
2021
Q3
$645K Sell
75,864
-77,395
-50% -$1.06M 0.21% 97
2021
Q2
$3.21M Sell
153,259
-154,129
-50% -$2.37M 0.77% 30
2021
Q1
$3.01M Buy
307,388
+92,714
+43% +$913K 0.67% 32
2020
Q4
$1.53M Sell
214,674
-49,284
-19% -$270K 0.39% 54
2020
Q3
$832K Buy
263,958
+34,367
+15% +$117K 0.46% 71
2020
Q2
$673K Buy
229,591
+24,342
+12% +$50.5K 0.5% 69
2020
Q1
$279K Sell
205,249
-185,882
-48% -$523K 0.23% 105
2019
Q4
$1.03M Buy
+391,131
New +$948K 0.41% 79

Other funds holding HYRE

Invenomic Capital Management's HYRE Position: Q4 2022 in Review

Invenomic Capital Management sold out of HyreCar Inc. Common Stock (HYRE) in Q4 2022, closing a stake of 502,881 shares — an estimated $463K sold.

Invenomic Capital Management first reported a position in HYRE in Q4 2019 and held it in 12 quarters. The position peaked at $3.21M in Q2 2021. 35 funds tracked by Wall St. Rank hold HYRE as of Q4 2022.

  • Invenomic Capital Management reported no remaining HyreCar Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Invenomic Capital Management sold 502,881 HyreCar Inc. Common Stock shares in Q4 2022, an estimated $463K.
  • Invenomic Capital Management first reported a position in HyreCar Inc. Common Stock in Q4 2019 and held it in 12 quarters.
  • Invenomic Capital Management's HyreCar Inc. Common Stock position peaked at $3.21M in Q2 2021.
  • 35 funds tracked by Wall St. Rank held HyreCar Inc. Common Stock as of Q4 2022.

Based on Invenomic Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.